Given the strong connection between IL-8 and neutrophils, it is perhaps unsurprising that the peripheral blood neutrophil-to-lymphocyte ratio (NLR) has emerged as a significant prognostic biomarker in cancer. The gene discussed is CXCL8; the disease is cancer.